Not logged in
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
SavePhase I study with expansion cohorts to assess the safety, tolerability, and activity of oral paclitaxel (oPac) plus encequidar (E) in combination with pembrolizumab (Pem) in subjects with advanced solid malignancies
Ma, W. W.; Singh, P.; Manochakian, R.; Yoon, H.; Adjei, A. A.; Lou, Y.; Cutler, D.; Landers, D.; Chan, W-K.; Zhi, J.; Kwan, R.
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save